The effect of basal–bolus therapy varies with baseline 1,5‐anhydroglucitol level in people with Type 2 diabetes: a post hoc analysis

AIMS: To investigate the impact of baseline 1,5‐anhydroglucitol on the treatment effect of basal–bolus therapy in people with Type 2 diabetes. METHODS: Post hoc analysis of onset 3, an 18‐week, randomized, phase 3 trial evaluating the efficacy and safety of fast‐acting insulin aspart in basal–bolus...

Descripción completa

Detalles Bibliográficos
Autores principales: Heller, S., Bowering, K., Raskin, P., Liebl, A., Buchholtz, K., Gorst‐Rasmussen, A., Pieber, T. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099439/
https://www.ncbi.nlm.nih.gov/pubmed/29802636
http://dx.doi.org/10.1111/dme.13693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099439/
https://www.ncbi.nlm.nih.gov/pubmed/29802636
http://dx.doi.org/10.1111/dme.13693

Ejemplares similares